Skip to main content
Top
Published in: Urolithiasis 5/2008

01-10-2008 | Original Paper

Intestinal hyperabsorption of calcium and low bone turnover in hypercalciuric postmenopausal osteoporosis

Authors: Clarita V. Odvina, John R. Poindexter, Roy D. Peterson, Joseph E. Zerwekh, Charles Y. C. Pak

Published in: Urolithiasis | Issue 5/2008

Login to get access

Abstract

Hypercalciuria of intestinal origin has been linked with bone loss in calcium nephrolithiasis and idiopathic osteoporosis. This retrospective data analysis was performed to explore potential pathogenetic link between intestinal hyperabsorption of calcium and postmenopausal osteoporosis. Data were retrieved from postmenopausal women who were evaluated for osteoporosis or osteopenia at the Mineral Metabolism Clinic of UT Southwestern Medical Center. A total of 319 patients underwent the test of calciuric response to oral calcium load to obtain an indirect measure of intestinal calcium absorption. Serum and urinary biochemistry and L2–L4 bone mineral density (BMD) were compared between five quintiles of calciuric response. There was a statistically significant trend toward a rise in 24-h urinary calcium and a decrease in urinary deoxypyridinoline (DPD) and BMD, with increasing order of quintiles. The presentation of those in the 1st quintile was consistent with vitamin D insufficiency or deficiency, with impaired calcium absorption, secondary hyperparathyroidism, and stimulated bone turnover (high normal urinary DPD). In contrast, patients in the 5th quintile displayed a picture of absorptive hypercalciuria of stone disease, with intestinal hyperabsorption of calcium, high or high normal urinary calcium and suppressed bone turnover (low or low normal urinary DPD). Thus, the assessment of intestinal calcium absorption in a seemingly homogeneous group of postmenopausal women with osteoporosis or osteopenia revealed a spectrum of calciuric response whose extremes may represent two physiologically distinct subtypes that have important diagnostic and therapeutic implications.
Literature
1.
go back to reference Pietschmann F, Breslau NA, Pak CYC (1992) Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7:1383–1388PubMed Pietschmann F, Breslau NA, Pak CYC (1992) Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7:1383–1388PubMed
2.
go back to reference Caudarella R, Vescini F, Buffa A, Sinicropi G, Rizzoli E, La Manna G et al (2003) Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 16:260–266PubMed Caudarella R, Vescini F, Buffa A, Sinicropi G, Rizzoli E, La Manna G et al (2003) Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 16:260–266PubMed
3.
go back to reference Giannini S, Nobile M, Sartori L, Calò L, Tasca A, Dalle Carbonare L et al (1998) Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clin Nephrol 50:94–100PubMed Giannini S, Nobile M, Sartori L, Calò L, Tasca A, Dalle Carbonare L et al (1998) Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clin Nephrol 50:94–100PubMed
4.
go back to reference Heller HJ, Zerwekh JE, Gottschalk FA, Pak CYC (2007) Increased bone resorption and reduced bone formation in moderate-severe absorptive hypercalciuria: bone histomorphometric analysis and alendronate challenge. Kidney Int 71:808–815. doi:10.1038/sj.ki.5002181 PubMedCrossRef Heller HJ, Zerwekh JE, Gottschalk FA, Pak CYC (2007) Increased bone resorption and reduced bone formation in moderate-severe absorptive hypercalciuria: bone histomorphometric analysis and alendronate challenge. Kidney Int 71:808–815. doi:10.​1038/​sj.​ki.​5002181 PubMedCrossRef
5.
go back to reference Heilberg IP, Martini LA, Szejnfeld VL, Carvalho AB, Draibe SA, Ajzen H et al (1994) Bone disease in calcium stone forming patients. Clin Nephrol 42:175–182PubMed Heilberg IP, Martini LA, Szejnfeld VL, Carvalho AB, Draibe SA, Ajzen H et al (1994) Bone disease in calcium stone forming patients. Clin Nephrol 42:175–182PubMed
6.
go back to reference Heiberg IP, Weisinger JR (2006) Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens 15:393–402 Heiberg IP, Weisinger JR (2006) Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens 15:393–402
7.
go back to reference Malluce HH, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry SG (1980) Abnormal histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 50:654–658 Malluce HH, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry SG (1980) Abnormal histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 50:654–658
8.
go back to reference Steiniche T, Moskilde L, Christensen MS, Melsen F (1988) A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. APMIS 97:309–316 Steiniche T, Moskilde L, Christensen MS, Melsen F (1988) A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. APMIS 97:309–316
9.
go back to reference Weisinger JR, Alonzo E, Bellorin-Font F, Blasini AM, Rodriguez MA, Paz-Marinez V et al (1996) Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49:244–250. doi:10.1038/ki.1996.34 PubMedCrossRef Weisinger JR, Alonzo E, Bellorin-Font F, Blasini AM, Rodriguez MA, Paz-Marinez V et al (1996) Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49:244–250. doi:10.​1038/​ki.​1996.​34 PubMedCrossRef
10.
go back to reference Zerwekh JE, Sakhee K, Breslau NA, Gottschalk F, Pak CYC (1992) Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporos Int 2:128–134. doi:10.1007/BF01623819 PubMedCrossRef Zerwekh JE, Sakhee K, Breslau NA, Gottschalk F, Pak CYC (1992) Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporos Int 2:128–134. doi:10.​1007/​BF01623819 PubMedCrossRef
11.
13.
go back to reference Giannini S, Nobile M, Dalle Carbonare L, Lodetti MG, Sella S, Vittadello G et al (2003) Hypercalciuria is a common and important finding in postmeopausal women with osteoporosis. Eur J Endocrinol 149:209–213. doi:10.1530/eje.0.1490209 PubMedCrossRef Giannini S, Nobile M, Dalle Carbonare L, Lodetti MG, Sella S, Vittadello G et al (2003) Hypercalciuria is a common and important finding in postmeopausal women with osteoporosis. Eur J Endocrinol 149:209–213. doi:10.​1530/​eje.​0.​1490209 PubMedCrossRef
14.
go back to reference Tannebaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D et al (2002) Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87:4431–4437. doi:10.1210/jc.2002-020275 CrossRef Tannebaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D et al (2002) Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87:4431–4437. doi:10.​1210/​jc.​2002-020275 CrossRef
15.
go back to reference Feitag A, Barzel US (2002) Differential diagnosis of osteoporosis. Gerontology 48:90–102 Feitag A, Barzel US (2002) Differential diagnosis of osteoporosis. Gerontology 48:90–102
17.
go back to reference Painter SE, Kleerekoper M, Camacho PM (2006) Secondary osteoporosis: a review of the recent evidence. Endocr Pract 12:436–445PubMed Painter SE, Kleerekoper M, Camacho PM (2006) Secondary osteoporosis: a review of the recent evidence. Endocr Pract 12:436–445PubMed
19.
go back to reference Pak CYC, Kaplan R, Bone H, Townsend J, Waters O (1975) A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 292:497–500PubMed Pak CYC, Kaplan R, Bone H, Townsend J, Waters O (1975) A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 292:497–500PubMed
20.
go back to reference Broadus AE, Dominguez D, Bartter FC (1978) Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups. J Clin Endocrinol Metab 47:751–760PubMed Broadus AE, Dominguez D, Bartter FC (1978) Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups. J Clin Endocrinol Metab 47:751–760PubMed
21.
go back to reference Harvey JA, Zobitz MM, Pak CYC (1988) Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 3:253–258PubMedCrossRef Harvey JA, Zobitz MM, Pak CYC (1988) Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 3:253–258PubMedCrossRef
23.
go back to reference Schuetter SA, Knowles JB (1988) Intestinal absorption of Ca(H2PO4)2 and Ca citrate compared by two methods. Am J Clin Nutr 47:884–888 Schuetter SA, Knowles JB (1988) Intestinal absorption of Ca(H2PO4)2 and Ca citrate compared by two methods. Am J Clin Nutr 47:884–888
26.
go back to reference Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT et al (2005) Prevalence of vitamin D insufficiency among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90:3215–3224. doi:10.1210/jc.2004-2364 PubMedCrossRef Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT et al (2005) Prevalence of vitamin D insufficiency among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90:3215–3224. doi:10.​1210/​jc.​2004-2364 PubMedCrossRef
28.
go back to reference Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CYC (1977) The role of 1α, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59:756–760. doi:10.1172/JCI108696 PubMedCrossRef Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CYC (1977) The role of 1α, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59:756–760. doi:10.​1172/​JCI108696 PubMedCrossRef
29.
go back to reference Broadus AE, Erickson SB, Gertner JM, Cooper K, Dobbins JW (1984) An experimental human model of 1, 25-dihydroxy vitamin D-mediated hypercalciuria. J Clin Endocrinol Metab 58:161–169PubMedCrossRef Broadus AE, Erickson SB, Gertner JM, Cooper K, Dobbins JW (1984) An experimental human model of 1, 25-dihydroxy vitamin D-mediated hypercalciuria. J Clin Endocrinol Metab 58:161–169PubMedCrossRef
30.
go back to reference Broadus AE, Insogna KL, Lang R, Ellison AF, Dreyer BE (1984) Evidence of disordered control of 1, 25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 311:73–80PubMed Broadus AE, Insogna KL, Lang R, Ellison AF, Dreyer BE (1984) Evidence of disordered control of 1, 25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 311:73–80PubMed
31.
go back to reference Breslau NA, Preminger GM, Adams BV, Otey J, Pak CYC (1992) Use of ketoconazole to probe the pathogenetic importance of 1, 25-dihydroxyvitamin D in absorptive hypercalciuria. J Clin Endocrinol Metab 75:1446–1452. doi:10.1210/jc.75.6.1446 PubMedCrossRef Breslau NA, Preminger GM, Adams BV, Otey J, Pak CYC (1992) Use of ketoconazole to probe the pathogenetic importance of 1, 25-dihydroxyvitamin D in absorptive hypercalciuria. J Clin Endocrinol Metab 75:1446–1452. doi:10.​1210/​jc.​75.​6.​1446 PubMedCrossRef
32.
go back to reference Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, Kathpalia PP, DeLuca HF, Bushinsky DA et al (2005) Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 20:447–454. doi:10.1359/JBMR.041120 PubMedCrossRef Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, Kathpalia PP, DeLuca HF, Bushinsky DA et al (2005) Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 20:447–454. doi:10.​1359/​JBMR.​041120 PubMedCrossRef
33.
go back to reference Reed BY, Gitomer WL, Heller HJ, Hsu MC, Lempke M, Padalino P et al (2002) Identification and characterization of a gene with base substitutions associated with absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 87:1476–1485. doi:10.1210/jc.87.4.1476 PubMedCrossRef Reed BY, Gitomer WL, Heller HJ, Hsu MC, Lempke M, Padalino P et al (2002) Identification and characterization of a gene with base substitutions associated with absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 87:1476–1485. doi:10.​1210/​jc.​87.​4.​1476 PubMedCrossRef
34.
go back to reference Odvina CV, Zerwekh ZE, Rao DS, Maalouf N, Gottschalk F, Pak CYC (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1291–1301 Odvina CV, Zerwekh ZE, Rao DS, Maalouf N, Gottschalk F, Pak CYC (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1291–1301
Metadata
Title
Intestinal hyperabsorption of calcium and low bone turnover in hypercalciuric postmenopausal osteoporosis
Authors
Clarita V. Odvina
John R. Poindexter
Roy D. Peterson
Joseph E. Zerwekh
Charles Y. C. Pak
Publication date
01-10-2008
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 5/2008
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-008-0146-4

Other articles of this Issue 5/2008

Urolithiasis 5/2008 Go to the issue